Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Horwell

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Neuropeptides|July 1, 1991
Studies on the effect of systemic PD134308 (CAM 958) in spinal reflex and pain models with special reference to interaction with morphine and intrathecal galaninZ Wiesenfeld-Hallin, X J Xu, J Hughes, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexesZ Wiesenfeld-Hallin, X J Xu, J Hughes, et al.
British Journal of Pharmacology|March 1, 1992
CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the ratX J Xu, Z Wiesenfeld-Hallin, J Hughes, et al.
Journal of Medicinal Chemistry|October 27, 1995
Quantitative structure-activity relationships (QSARs) of N-terminus fragments of NK1 tachykinin antagonists: a comparison of classical QSARs and three-dimensional QSARs from similarity matricesD C Horwell, W Howson, M Higginbottom, et al.
Journal of Medicinal Chemistry|January 1, 1990
Highly selective kappa-opioid analgesics. 3. Synthesis and structure-activity relationships of novel N-[2-(1-pyrrolidinyl)-4- or -5-substituted-cyclohexyl]arylacetamide derivativesP R Halfpenny, D C Horwell, J Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Synthesis and biological evaluation of conformationally restricted Gabapentin analoguesJ M Receveur, J S Bryans, M J Field, et al.
Bioorganic & Medicinal Chemistry|July 10, 1999
An in vitro investigation into conformational aspects of gabapentinJ S Bryans, D C Horwell, G S Ratcliffe, et al.
Bioorganic & Medicinal Chemistry|September 1, 1993
Conformationally restricted analogues of the potent CCK-B antagonist CI-988M Higginbottom, D R Hill, D C Horwell, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
The design and synthesis of the high efficacy, non-peptide CCK1 receptor agonist PD170292N Bernad, B G Burgaud, D C Horwell, et al.
British Journal of Pharmacology|October 1, 1995
Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosaA Heinemann, M Jocic, U Holzer-Petsche, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Neuropeptides|July 1, 1991
Studies on the effect of systemic PD134308 (CAM 958) in spinal reflex and pain models with special reference to interaction with morphine and intrathecal galaninZ Wiesenfeld-Hallin, X J Xu, J Hughes, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexesZ Wiesenfeld-Hallin, X J Xu, J Hughes, et al.
British Journal of Pharmacology|March 1, 1992
CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the ratX J Xu, Z Wiesenfeld-Hallin, J Hughes, et al.
Journal of Medicinal Chemistry|October 27, 1995
Quantitative structure-activity relationships (QSARs) of N-terminus fragments of NK1 tachykinin antagonists: a comparison of classical QSARs and three-dimensional QSARs from similarity matricesD C Horwell, W Howson, M Higginbottom, et al.
Journal of Medicinal Chemistry|January 1, 1990
Highly selective kappa-opioid analgesics. 3. Synthesis and structure-activity relationships of novel N-[2-(1-pyrrolidinyl)-4- or -5-substituted-cyclohexyl]arylacetamide derivativesP R Halfpenny, D C Horwell, J Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Synthesis and biological evaluation of conformationally restricted Gabapentin analoguesJ M Receveur, J S Bryans, M J Field, et al.
Bioorganic & Medicinal Chemistry|July 10, 1999
An in vitro investigation into conformational aspects of gabapentinJ S Bryans, D C Horwell, G S Ratcliffe, et al.
Bioorganic & Medicinal Chemistry|September 1, 1993
Conformationally restricted analogues of the potent CCK-B antagonist CI-988M Higginbottom, D R Hill, D C Horwell, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
The design and synthesis of the high efficacy, non-peptide CCK1 receptor agonist PD170292N Bernad, B G Burgaud, D C Horwell, et al.
British Journal of Pharmacology|October 1, 1995
Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosaA Heinemann, M Jocic, U Holzer-Petsche, et al.
Pageof 4